Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,079
Closed -$233K 2196
2026
Q1
$233K Sell
3,079
-12,210
-80% -$918K ﹤0.01% 1896
2025
Q4
$1.14M Sell
15,289
-1,385
-8% -$101K 0.01% 999
2025
Q3
$1.13M Sell
16,674
-4,547
-21% -$302K 0.01% 995
2025
Q2
$1.38M Sell
21,221
-1,773
-8% -$106K 0.02% 892
2025
Q1
$1.42M Buy
22,994
+4,457
+24% +$295K 0.02% 862
2024
Q4
$1.34M Sell
18,537
-7,290
-28% -$570K 0.02% 844
2024
Q3
$2.1M Sell
25,827
-1,757
-6% -$141K 0.03% 650
2024
Q2
$2.05M Buy
27,584
+1,638
+6% +$123K 0.03% 630
2024
Q1
$2.02M Buy
25,946
+6,270
+32% +$466K 0.03% 651
2023
Q4
$1.41M Sell
19,676
-7,488
-28% -$521K 0.02% 749
2023
Q3
$1.89M Sell
27,164
-1,588
-6% -$120K 0.03% 589
2023
Q2
$2.33M Buy
28,752
+4,290
+18% +$351K 0.04% 501
2023
Q1
$1.97M Buy
24,462
+463
+2% +$37.3K 0.04% 541
2022
Q4
$1.8M Buy
23,999
+7,566
+46% +$539K 0.04% 552
2022
Q3
$1.06M Sell
16,433
-3,196
-16% -$221K 0.02% 704
2022
Q2
$1.36M Buy
+19,629
New +$1.46M 0.03% 629

Other funds holding HOLX

Atria Investments's HOLX Position: Q2 2026 in Review

Atria Investments sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,079 shares — an estimated $233K sold.

Atria Investments first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $2.33M in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Atria Investments reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Atria Investments sold 3,079 Hologic shares in Q2 2026, an estimated $233K.
  • Atria Investments first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
  • Atria Investments's Hologic position peaked at $2.33M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.